当前位置:首页 - 行情中心 - 亨迪药业(301211) - 财务分析

亨迪药业

(301211)

  

流通市值:13.69亿  总市值:54.75亿
流通股本:7200.00万   总股本:2.88亿

亨迪药业(301211)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.75亿元,每股收益0.26元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益229542.89万元,未分配利润19862.20万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产243706.91万元,负债14164.02万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入333,993,687.09241,866,955.11138,059,120.72663,025,874.35
营业总成本263,843,342.98164,433,150.6894,973,688.59467,721,232.76
营业利润82,958,023.6681,129,769.4444,340,764.81205,334,070.12
利润总额82,580,556.8380,885,172.544,323,592.98202,816,100.34
净利润74,661,546.2868,496,011.3137,381,597.2176,116,201.67
其他综合收益----
综合收益总额74,661,546.2868,496,011.3137,381,597.2176,116,201.67
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,876,829,237.791,901,026,904.252,062,714,828.892,098,949,170.23
非流动资产合计560,239,858.04527,792,548.05479,549,434.74447,621,805.56
资产总计2,437,069,095.832,428,819,452.32,542,264,263.632,546,570,975.79
流动负债合计128,361,400.85126,960,878.85133,340,394.72175,141,355.55
非流动负债合计13,278,812.7213,635,299.8213,987,986.7714,744,778.82
负债合计141,640,213.57140,596,178.67147,328,381.49189,886,134.37
归属于母公司股东权益合计2,295,428,882.262,288,223,273.632,394,935,882.142,356,684,841.42
股东权益合计2,295,428,882.262,288,223,273.632,394,935,882.142,356,684,841.42
负债和股东权益合计2,437,069,095.832,428,819,452.32,542,264,263.632,546,570,975.79
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计358,511,330252,111,623.06121,441,224.56605,727,754.74
经营活动现金流出小计309,552,700.22220,153,835.39107,110,148.27468,664,279.03
经营活动产生的现金流量净额48,958,629.7831,957,787.6714,331,076.29137,063,475.71
投资活动现金流入小计88,261,830.3177,252,650.3111,114,035.31466,409
投资活动现金流出小计1,173,472,855.41644,032,788.1157,220,603.54207,935,114.16
投资活动产生的现金流量净额-1,085,211,025.1-566,780,137.8-46,106,568.23-207,468,705.16
筹资活动现金流入小计----
筹资活动现金流出小计138,240,000138,240,000-97,167,597.78
筹资活动产生的现金流量净额-138,240,000-138,240,000--97,167,597.78
汇率变动对现金及现金等价物的影响910,901.581,397,535.02551,001.483,810,470.86
现金及现金等价物净增加额-1,173,581,493.74-671,664,815.11-31,224,490.46-163,762,356.37
期末现金及现金等价物余额520,745,020.941,022,661,699.571,663,102,024.221,694,226,514.68
TOP↑